Pluripotent State Induction in Mouse Embryonic Fibroblast Using mRNAs of Reprogramming Factors

El-Sayed, Ahmed Kamel; Zhentao Zhang; Lei Zhang; Zhiyong Liu; Abbott, Louise C.; Yani Zhang; Bichun Li
December 2014
International Journal of Molecular Sciences;2014, Vol. 15 Issue 12, p21840
Academic Journal
Reprogramming of somatic cells has great potential to provide therapeutic treatments for a number of diseases as well as provide insight into mechanisms underlying early embryonic development. Improvement of induced Pluripotent Stem Cells (iPSCs) generation through mRNA-based methods is currently an area of intense research. This approach provides a number of advantages over previously used methods such as DNA integration and insertional mutagenesis. Using transfection of specifically synthesized mRNAs of various pluripotency factors, we generated iPSCs from mouse embryonic fibroblast (MEF) cells. The genetic, epigenetic and functional properties of the iPSCs were evaluated at different times during the reprogramming process. We successfully introduced synthesized mRNAs, which localized correctly inside the cells and exhibited efficient and stable translation into proteins. Our work demonstrated a robust up-regulation and a gradual promoter de-methylation of the pluripotency markers, including non-transfected factors such as Nanog, SSEA-1 (stage-specific embryonic antigen 1) and Rex-1 (ZFP-42, zinc finger protein 42). Using embryonic stem cells (ESCs) conditions to culture the iPS cells resulted in formation of ES-like colonies after approximately 12 days with only five daily repeated transfections. The colonies were positive for alkaline phosphatase and pluripotency-specific markers associated with ESCs. This study revealed the ability of pluripotency induction and generation of mouse mRNA induced pluripotent stem cells (mRNA iPSCs) using transfection of specifically synthesized mRNAs of various pluripotency factors into mouse embryonic fibroblast (MEF) cells. These generated iPSCs exhibited molecular and functional properties similar to ESCs, which indicate that this method is an efficient and viable alternative to ESCs and can be used for further biological, developmental and therapeutic investigations.


Related Articles

  • Generation of Human Induced Pluripotent Stem (Ips) Cells in Serum- and Feeder-Free Defined Culture and TGF-Î’1 Regulation of Pluripotency. Yamasaki, Sachiko; Taguchi, Yuki; Shimamoto, Akira; Mukasa, Hanae; Tahara, Hidetoshi; Okamoto, Tetsuji // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Human Embryonic Stem cells (hESCs) and human induced Pluripotent Stem cells (hiPSCs) are commonly maintained on inactivated mouse embryonic fibroblast as feeder cells in medium supplemented with FBS or proprietary replacements. Use of culture medium containing undefined or unknown components has...

  • Generation of iPSCs by Nonintegrative RNA-Based Reprogramming Techniques: Benefits of Self-Replicating RNA versus Synthetic mRNA. Steinle, Heidrun; Weber, Marbod; Behring, Andreas; Mau-Holzmann, Ulrike; Schlensak, Christian; Wendel, Hans Peter; Avci-Adali, Meltem // Stem Cells International;6/19/2019, p1 

    The reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) is gaining in importance in the fields of regenerative medicine, tissue engineering, and disease modeling. Patient-specific iPSCs have as an unlimited cell source a tremendous potential for generating various types of...

  • Mechanisms and models of somatic cell reprogramming. Buganim, Yosef; Faddah, Dina A.; Jaenisch, Rudolf // Nature Reviews Genetics;Jun2013, Vol. 14 Issue 6, p427 

    Conversion of somatic cells to pluripotency by defined factors is a long and complex process that yields embryonic-stem-cell-like cells that vary in their developmental potential. To improve the quality of resulting induced pluripotent stem cells (iPSCs), which is important for potential...

  • Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective. Liang, Gaoyang; Zhang, Yi // Cell Research;Jan2013, Vol. 23 Issue 1, p49 

    Pluripotent stem cells, like embryonic stem cells (ESCs), have specialized epigenetic landscapes, which are important for pluripotency maintenance. Transcription factor-mediated generation of induced pluripotent stem cells (iPSCs) requires global change of somatic cell epigenetic status into an...

  • Direct reprogramming of adult cells: avoiding the pluripotent state. Kelaini, Sophia; Cochrane, Amy; Margariti, Andriana // Stem Cells & Cloning: Advances & Applications;2014, Vol. 7, p19 

    The procedure of using mature, fully differentiated cells and inducing them toward other cell types while bypassing an intermediate pluripotent state is termed direct reprogramming. Avoiding the pluripotent stage during cellular conversions can be achieved either through ectopic expression of...

  • The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming. Mansour, Abed AlFatah; Gafni, Ohad; Weinberger, Leehee; Zviran, Asaf; Ayyash, Muneef; Rais, Yoach; Krupalnik, Vladislav; Zerbib, Mirie; Amann-Zalcenstein, Daniela; Maza, Itay; Geula, Shay; Viukov, Sergey; Holtzman, Liad; Pribluda, Ariel; Canaani, Eli; Horn-Saban, Shirley; Amit, Ido; Novershtern, Noa; Hanna, Jacob H. // Nature;8/16/2012, Vol. 488 Issue 7411, p409 

    Induced pluripotent stem cells (iPSCs) can be derived from somatic cells by ectopic expression of different transcription factors, classically Oct4 (also known as Pou5f1), Sox2, Klf4 and Myc (abbreviated as OSKM). This process is accompanied by genome-wide epigenetic changes, but how these...

  • THERAPEUTIC TRANSDIFFERENTIATION: A NOVEL APPROACH FOR ISCHEMIC SYNDROMES. Connell, Jennifer P.; Kodali, Santhisri; Cooke, John P. // Methodist DeBakey Cardiovascular Journal;Sep2015, Vol. 11 Issue 3, p176 

    The technological development of induced pluripotent stem cells (iPSCs) has overcome many of the limitations of adult and embryonic stem cells. We have found that activation of innate immunity signaling is necessary for this process, as it facilitates epigenetic plasticity in cells by a process...

  • Therapeutic potential of somatic cell nuclear transfer for degenerative disease caused by mitochondrial DNA mutations. Greggains, Gareth D.; Lister, Lisa M.; Tuppen, Helen A. L.; Zhang, Qi; Needham, Louise H.; Prathalingam, Nilendran; Hyslop, Louise A.; Craven, Lyndsey; Polanski, Zbigniew; Murdoch, Alison P.; Turnbull, Douglass M.; Herbert, Mary // Scientific Reports;1/24/2014, p1 

    Induced pluripotent stem cells (iPSCs) hold much promise in the quest for personalised cell therapies. However, the persistence of founder cell mitochondrial DNA (mtDNA) mutations limits the potential of iPSCs in the development of treatments for mtDNA disease. This problem may be overcome by...

  • The Application of Human iPSCs in Neurological Diseases: From Bench to Bedside. Xie, Nina; Tang, Beisha // Stem Cells International;1/6/2016, p1 

    In principle, induced pluripotent stem cells (iPSCs) are generated from somatic cells by reprogramming and gaining the capacity to self-renew indefinitely as well as the ability to differentiate into cells of different lineages. Human iPSCs have absolute advantages over human embryonic stem...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics